Related Experiment Video
Updated: Mar 4, 2026

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Diabetic Cardiomyopathy: Current Approach and Potential Diagnostic and Therapeutic Targets
Georgiana-Emmanuela Gilca1, Gabriela Stefanescu2, Oana Badulescu1
1Department of Pathophysiology, Faculty of Medicine, University of Medicine and Pharmacy "Grigore T. Popa" Iasi, Iasi, Romania.
Insights
Diabetic cardiomyopathy (DCM) is a serious complication of diabetes mellitus, often silent and underdiagnosed. Identifying its mechanisms and diagnostic markers is crucial for better patient outcomes.
Area of Science:
- Cardiology
- Endocrinology
- Pathophysiology
Background:
- Diabetic cardiomyopathy (DCM) is a significant cause of death in diabetic patients, often overlooked.
- DCM involves complex mechanisms like oxidative stress, mitochondrial dysfunction, and extracellular matrix remodeling.
- It silently progresses, increasing heart failure risk and worsening prognosis in diabetes mellitus patients.
Purpose of the Study:
- To highlight the clinical relevance of DCM in diabetes mellitus.
- To discuss the intricate pathophysiological mechanisms underlying DCM.
- To emphasize the need for improved diagnostics and therapeutic strategies for DCM.
Main Methods:
- Review of existing literature on diabetic cardiomyopathy.
- Analysis of pathophysiological mechanisms including oxidative stress, calcium handling, and mitochondrial function.
- Discussion of diagnostic challenges and potential therapeutic targets.
Main Results:
- DCM is a common, yet underdiagnosed, complication of diabetes.
- Multiple factors contribute to DCM, including oxidative stress and impaired cardiomyocyte function.
- Current diagnostic tools are limited in early-stage DCM detection.
Conclusions:
- DCM is a critical complication of diabetes mellitus with significant impact on cardiac function.
- Early diagnosis and targeted therapies are essential for improving DCM patient prognosis.
- Further research into pathophysiological landmarks and diagnostic markers is vital.
Abstract:
Although ischemic heart disease is the major cause of death in diabetic patients, diabetic cardiomyopathy (DCM) is increasingly recognized as a clinically relevant entity. Considering that it comprises a variety of mechanisms and effects on cardiac function, increasing the risk of heart failure and worsening the prognosis of this patient category, DCM represents an important complication of diabetes mellitus, with a silent development in its earlier stages, involving intricate pathophysiological mechanisms, including oxidative stress, defective calcium handling, altered mitochondrial function, remodeling of the extracellular matrix, and consequent deficient cardiomyocyte contractility. While DCM is common in diabetic asymptomatic patients, it is frequently underdiagnosed, due to few diagnostic possibilities in its early stages. Moreover, since a strategy for prevention and treatment in order to improve the prognosis of DCM has not been established, it is important to identify clear pathophysiological landmarks, to pinpoint the available diagnostic possibilities and to spot potential therapeutic targets.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy VI: Nursing Management

